Table 3.
Distribution of SNPs in IL-27 among NMIBC and MIBC patients
rs153109 | rs17855750 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Model | Genotype | NMIBC | MIBC | OR (95 % CI)a | P valuea | Genotype | NMIBC | MIBC | OR (95 % CI)a | P valuea |
N = 176 (%) | N = 156 (%) | N = 176 (%) | N = 156 (%) | |||||||
Codominant | AA | 66 (37.5 %) | 61 (39.1 %) | 1.00 (reference) | 0.99 | TT | 149 (84.7 %) | 126 (80.8 %) | 1.00 (reference) | 0.076 |
AG | 87 (49.4 %) | 73 (46.8 %) | 1.04 (0.60–1.81) | TG | 26 (14.8 %) | 27 (17.3 %) | 0.53 (0.26–1.09) | |||
GG | 23 (13.1 %) | 22 (14.1 %) | 1.02 (0.46–2.27) | GG | 1 (0.6 %) | 3 (1.9 %) | 0.15 (0.01–1.84) | |||
Dominant | AA | 66 (37.5 %) | 61 (39.1 %) | 1.00 (reference) | 0.88 | TT | 149 (84.7 %) | 126 (80.8 %) | 1.00 (reference) | 0.042 |
AG/GG | 110 (62.5 %) | 95 (60.9 %) | 1.04 (0.62–1.75) | TG/GG | 27 (15.3 %) | 30 (19.2 %) | 2.04 (1.02–4.17) | |||
Recessive | AA/AG | 153 (86.9 %) | 134 (85.9 %) | 1.00 (reference) | 0.99 | TT/TG | 175 (99.4 %) | 153 (98.1 %) | 1.00 (reference) | 0.14 |
GG | 23 (13.1 %) | 22 (14.1 %) | 1.00 (0.48–2.09) | GG | 1 (0.6 %) | 3 (1.9 %) | 0.17 (0.01–2.07) | |||
Overdominant | AA/GG | 89 (50.6 %) | 83 (53.2 %) | 1.00 (reference) | 0.88 | TT/GG | 150 (85.2 %) | 129 (82.7 %) | 1.00 (reference) | 0.1 |
AG | 87 (49.4 %) | 73 (46.8 %) | 1.04 (0.63–1.73) | TG | 26 (14.8 %) | 27 (17.3 %) | 0.55 (0.27–1.13) | |||
Allele | ||||||||||
A | 219 (62.2) | 195 (62.5) | 0.99 (0.72–1.35) | 0.94 | T | 324 (92.0) | 279 (89.4) | 1.37 (0.81–2.32) | 0.28 | |
G | 133 (37.8) | 117 (37.5) | G | 28 (8.0) | 33 (10.6) |
N corresponds to the number of individuals
aAdjusted by age, sex and smoking status
Boldfaced values indicate a significant difference at the 5 % level